Table 1.
Characteristic | No. (%) or median [IQR] |
---|---|
Age, yr | 66 [60–74] |
Male sex | 77 (46.1) |
Smoking status | |
Smoker | 37 (22.2) |
Former smoker | 75 (44.9) |
Nonsmoker | 51 (30.5) |
Unknown | 4 (2.4) |
Previous cancer | 47 (28.1) |
Previous lung resection | 4 (2.4) |
Tumour location | |
Right upper lobe | 65 (38.9) |
Right middle lobe | 19 (11.4) |
Right lower lobe | 32 (19.2) |
Left upper lobe | 27 (16.2) |
Left lower lobe | 24 (14.4) |
Tumour size, cm | 2.5 [1.5–3.2] |
Resection type | |
Lobectomy | 141 (84.4) |
Segmental resection | 13 (7.8) |
Nonanatomic (wedge) | 8 (4.8) |
Bilobectomy | 5 (3.0) |
T stage | |
T1 | 86 (51.5) |
T2 | 54 (32.3) |
T3 | 7 (4.2) |
T4 | 2 (1.2) |
Benign | 10 (6.0) |
Metastases to lung | 8 (4.8) |
Cumulative stage | |
Occult cancer | 2 (1) |
1A | 71 (43) |
1B | 40 (24) |
2A | 15 (9) |
2B | 6 (4) |
3A | 14 (8) |
4 | 7 (4) |
Benign tumour | 10 (6) |
FEV1, % predicted | 85 [71–94] |
DLCO, % predicted | 80 [69–93] |
DLCO = diffusing capacity of the lungs for carbon monoxide; FEV1 = forced expiratory volume in 1 second; IQR = interquartile range; RATS = robotic-assisted thoracic surgery.